Cost-effectiveness of atypical antipsychotics for the management of schizophrenia in the UK . [electronic resource]
Producer: 20110531Description: 3275-85 p. digitalISSN:- 1473-4877
- Algorithms
- Antipsychotic Agents -- adverse effects
- Aripiprazole
- Benzodiazepines -- adverse effects
- Clinical Trials, Phase I as Topic -- economics
- Cost-Benefit Analysis
- Decision Support Techniques
- Follow-Up Studies
- Health Care Costs
- Health Resources -- economics
- Humans
- Olanzapine
- Patient Acceptance of Health Care
- Piperazines -- adverse effects
- Quality-Adjusted Life Years
- Quinolones -- adverse effects
- Randomized Controlled Trials as Topic -- economics
- Schizophrenia -- drug therapy
- United Kingdom -- epidemiology
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.